DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Procedure Numbers for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedPro" report to their offering.
Despite the fact that autograft procedures are becoming less popular, they still account for a considerably large portion of dental bone grafting procedures across Europe. As a result, the dental biomaterial market is significantly underdeveloped in Europe, relative to the U.S. market.
A prevailing preference for xenograft materials characterizes the dental bone graft substitute market in Europe and very few regions have demonstrated a shift towards allograft materials. It is expected that stringent regulations and protocols set in place by the European Tissue and Cells Directive (EUTCD) will continue to limit the allograft market and overall dental biomaterial market in the future.
Other notable developments in the European dental biomaterial market include strategic partnerships between implant companies and biomaterial companies, increasing penetration of allograft materials and the introduction of innovative products that use new materials and composites of existing products.
Key Topics Covered:
1. Research Methodology
2. Disease Overview
2.1 Basic Anatomy
2.1.1 Dental Anatomy: Oral Cavity And Intraoral Landmarks
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostics
2.2.2 Indication For Dental Implant
220.127.116.11 Periodontal Disease
18.104.22.168 Dental Implant Procedures
2.3 Patient Demographics
2.3.1 General Dental Statistics
2.3.2 Tooth Loss Statistics
3. Country Profiles
4. Procedure Numbers
4.2 Dental Bone Grafting Procedure Numbers
4.2.1 Dental Bone Graft Substitute Penetration Rate
- Botiss Biomaterials
- Zimmer Biomet
- ACE Surgical
- Tecnoss Dental
For more information about this report visit http://www.researchandmarkets.com/research/p3jc2n/europe_procedure